We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A scientist holding a pipette.
Product News

Metrion Biosciences Enhances High Throughput Screening Services With Access to Enamine Compound Libraries

Access to compound collection enables greater flexibility and efficiencies in screening and target identification.
Double helix structure of DNA.
Product News

University of Liverpool To Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical

The UK’s Medical Research Council is funding a 10-patient Phase I study to deliver rapid personalised treatment for lung cancer patients.
Antibodies.
Product News

Therapeutic Potential of CD20 X CD3 Bispecific Antibodies

As of March 2024, the FDA has approved three CD20 × CD3 BsAbs: mosunetuzumab (Lunsumio) for relapsed or refractory follicular lymphoma (R/R FL), glofitamab (Columvi) for relapsed or refractory diffuse B cell lymphoma
Antibodies fight viruses.
Product News

Sino Biological Announces Services Partnership With Rapid Novor

Sino Biological and Rapid Novor partner to offer combined antibody development and sequencing services.
Drugs and a puzzle piece.
Product News

InSphero and PharmaNest Unveil a Promising Tool for MASH Drug Discovery

InSphero's Liver Disease team has published a groundbreaking peer-reviewed paper in Nature's Scientific Reports, challenging the limitations of in vitro models in MASH Drug Discovery.
Antibodies attacking viruses.
Product News

ProBioGen Partners With MAPP BIOPHARMACEUTICAL, INC. for Groundbreaking Development of Afucosylated Antibody Against Marburg Virus Disease

ProBioGen, is pleased to announce the execution of services and license agreements with MAPP BIOPHARMACEUTICAL, INC. to develop a cell line for an afucosylated antibody targeting Marburg virus (MARV) infection.
Advertisement